Protracted treatment with diazepam increases the turnover of putative endogenous ligands for the benzodiazepine/beta-carboline recognition site.

DBI (diazepam-binding inhibitor) is a putative neuromodulatory peptide isolated from rat brain that acts on gamma-aminobutyric acid-benzodiazepine-Cl- ionophore receptor complex inducing beta-carboline-like effects. We used a cDNA probe complementary to DBI mRNA and a specific antibody for rat DBI t...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Proc Natl Acad Sci U S A
Principais autores:	Miyata, M, Mocchetti, I, Ferrarese, C, Guidotti, A, Costa, E
Formato:	Artigo
Idioma:	Inglês
Publicado em:	National Academy of Sciences 1987
Assuntos:	Research Article
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC304447/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/3029781/ https://ncbi.nlm.nih.govhttps://doi.org/10.1073/pnas.84.5.1444
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!